Trials / Withdrawn
WithdrawnNCT03788694
Intranasal Ketamine for Suicidal Ideation in Veterans
Pilot Study of Open Label, Intranasal Ketamine for Suicidal Ideation in Veterans
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Bronx Veterans Medical Research Foundation, Inc · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the current study is to investigate the safety, efficacy, and feasibility of multiple doses of intranasal (IN) ketamine for suicidal ideation Veterans.
Detailed description
To address the significant need for effective treatment of suicidal ideation in Veterans, this trial is designed as an open label pilot study of intranasal ketamine in 15 people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | 8 doses of intranasal ketamine; 40 mg per dose. |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-01-31
- Completion
- 2020-04-30
- First posted
- 2018-12-27
- Last updated
- 2023-08-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03788694. Inclusion in this directory is not an endorsement.